Executive Summary
The PTAB found all 29 challenged claims unpatentable by a preponderance of evidence. The Board rejected the Patent Owner's argument that the invention was limited to RF neurotomy, adopting Petitioner's broader view of 'thermal ablation systems.'
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Avanos Medical, Inc. vs Stratus Medical, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Luxottica of America Inc.vsE-Vision Smart Optics, Inc.
The PTAB granted institution for IPR2025-01512, allowing Luxottica to challenge E-Vision's patent 11971612 on the merits.
Apple Incvs1LSS Inc.
The USPTO Board granted institution for IPR2025-01180, allowing the trial to proceed after determining the petitioner had a reasonable likelihood of prevailing on at least one challenged claim.
Merck Sharp & Dohme LLC et al.vsThe Johns Hopkins University
Merck Sharp & Dohme LLC successfully instituted an IPR against The Johns Hopkins University's patent, challenging claims related to anti-PD-1 antibodies for MSI-high cancer. The Board found sufficient evidence that prior art anticipated and rendered the claims obvious, leading to a trial institution decision.
SAP America, Inc. et al.vsCyandia, Inc.
The PTAB found that the challenged claims were unpatentable over prior art combinations under 35 U.S.C. §§ 102 and 103. The Board adopted a broad claim construction, defining 'current state' to include both online and offline device states, which facilitated the finding of obviousness.
Apple Inc.vsPoniatowski, Paul et al.
Apple Inc. successfully convinced the PTAB that its claims against Paul Poniatowski's patent were likely obvious over prior art references (Wang, Dua, Yong). The Board granted institution of IPR proceedings, moving the dispute toward trial in the District Court.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.